Last $1.40 USD
Change Today -0.19 / -11.95%
Volume 2.0K
MLSS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

220 South Orange Avenue

Livingston, NJ 07039

United States

Phone: 973-535-2717

Fax: 973-535-2829

Milestone Scientific Inc. provides technologies and solutions for the medical and dental markets in the United States, Canada, Asia, Africa, South America, and Europe. The company offers a proprietary, computer-controlled anesthetic delivery instrument, through the use of The Wand, a single use disposable handpiece. The instrument is marketed in dentistry under the trademark CompuDent, Wand Plus and STA (Single Tooth Anesthesia) and in medicine under the trademark CompuMed. CompuDent is suitable for all dental procedures that require local anesthetic. CompuMed and Wand Plus are suitable for medical procedures regularly performed in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. The instruments are sold in the United States and in approximately 47 countries worldwide. Product Platform STA Single Tooth Anesthesia Instrument The STA Instrument is a patented, computer-controlled local anesthesia delivery instrument that incorporates the ‘pressure feedback’ elements of the company’s patented CompuFlo technology, thereby allowing dentists to administer injections into the periodontal ligament space, effectively anesthetizing a single tooth. CompuDent CompuDent (also known as the Wand Plus internationally) is the company’s proprietary, patented Computer-Controlled Local Anesthetic Delivery (C-CLAD) instrument and predecessor of the STA Instrument. CompuDent delivers anesthesia at a precise and consistent rate below a patient’s pain threshold. CompuMed CompuMed is a patented computer-controlled injection instrument geared to the needs of the medical market and providing uses similar to CompuDent. CompuMed allows medical procedures, requiring intravenous sedation, to be performed with only local anesthesia due to dramatic pain reduction. The Wand The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments. It is an ergonomically designed and patented handpieces that enables all traditional and newer injections, such as AMSA, P-ASA and Modified-PDL. The pen-like grasp of The Wand allows bi-directional rotation during injection, which prevents needle deflection that occurs with a traditional syringe. Medical Instrument for Joint Venture In 2011, the company entered into a definitive joint venture agreement with Beijing 3H (Heart-Help-Health) Scientific Technology Co., Ltd. (Beijing 3H) for the development, commercialization, manufacture and marketing of epidural and intra-articular injection instruments. The company has a 50% interest in the joint venture and Beijing 3H together with other individuals, Bejing 3H also has a 50% interest in joint venture. Research and Development During the 2012 fiscal year, the company expensed $181,979, on research and development activities. Patents Computer Controlled Drug Delivery Systems: These patents include the following: Dental Anesthetic and Delivery Injection Unit, Design for a Dental Anesthetic Delivery System Holder, Design for a Dental Anesthetic Delivery System Housing, Design for a Dental Anesthetic Delivery System Handle, Cartridge Holder for Injection Device, Dental Anesthetic Delivery Injection Unit, Microprocessor-controlled Fluid Dispensing Apparatus, Pressure/Force Computer Controlled Drug Delivery System, Dental Anesthetic and Delivery Injection Unit with Automated Rate Control, Pressure/Force Computer Controlled Drug Delivery System with Exit Pressure, Pressure/Force Computer Controlled Drug Delivery System with Automated Charging, Drug Delivery System with Profiles, Cartridge Holder for Anesthetic and Delivery Injection Device, Design for Drive Unit for Anesthetic, Design for Drive Unit for Anesthetic, Drug Infusion Device with Tissue Identification Using Pressure Sensing, Computer Controlled Drug Delivery Systems with Pressure Sensing, Hand Piece for Fluid Administration, Self-Administration Injection System, and Computer controlled drug delivery system with dynamic pressure sensing. Engineered Sharps Injury Protection Devices: These patents include the following: Handpiece for Injection Device with a Retractable and Rotating Needle, Safety IV Catheter Device, Safety IV Catheter Infusion Device, and Handpiece for Injection Device with a Retractable and Rotating Needle. Regulation The company is subject to pervasive and continuing regulation by the U.S. Food and Drug Administration (FDA), whose regulations require manufacturers of medical devices to adhere to certain FDA’s Quality Instrument Regulation (QSR) requirements as defined by the FDC Act. QSR compliance requires testing, quality control and documentation procedures. History Milestone Scientific Inc. was founded in 1989. The company was incorporated in the state of Delaware in 1989.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLSS:US $1.40 USD -0.19

MLSS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLSS.
View Industry Companies
 

Industry Analysis

MLSS

Industry Average

Valuation MLSS Industry Range
Price/Earnings 19.0x
Price/Sales 2.8x
Price/Book 5.1x
Price/Cash Flow 19.3x
TEV/Sales 2.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MILESTONE SCIENTIFIC INC, please visit www.milesci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.